- Home
- ERNA vs FLYE Comparison
ERNA vs FLYE Comparison
Compare ERNA & FLYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ERNA | FLYE |
|---|---|---|
| Founded | 2018 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4M | 2.3M |
| IPO Year | 2021 | 2024 |
Fundamental Metrics
Financial Performance| Metric | ERNA | FLYE |
|---|---|---|
| Price | $1.94 | $1.80 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 24.9K | ★ 4.8M |
| Earning Date | 11-17-2026 | 12-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 31.29 | ★ 61.82 |
| EPS | N/A | ★ N/A |
| Revenue | $582,000.00 | ★ $19,063,357.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.84 | $1.22 |
| 52 Week High | $46.11 | $109.00 |
Technical Indicators
Market Signals| Indicator | ERNA | FLYE |
|---|---|---|
| Relative Strength Index (RSI) | 32.01 | 43.72 |
| Support Level | $1.84 | $1.51 |
| Resistance Level | $2.26 | $2.04 |
| Average True Range (ATR) | 0.17 | 0.43 |
| MACD | 0.06 | -0.09 |
| Stochastic Oscillator | 26.42 | 0.33 |
Price Performance
Historical ComparisonAbout ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a preclinical-stage synthetic allogeneic iMSC therapy company developing medicines to treat various forms of cancer and other diseases with high unmet medical needs. Its main product candidate, ERNA-101, capitalizes on the intrinsic tumor-homing ability of MSCs (mesenchymal stem cells) to slip through the tumor's defenses and to deliver potent pro-inflammatory factors directly to the tumor microenvironment. The firm's initial focus is to develop ERNA-101 in platinum-resistant ovarian cancer. Through another product candidate, ERNA-201, it is investigating anti-inflammatory cytokine (IL-10) secreting iMSCs in autoimmune disorders like rheumatoid arthritis. The company operates in a single reportable segment, the research and development of cellular therapies.
About FLYE Fly-E Group Inc.
Fly-E Group Inc is principally engaged in designing, installing and selling smart electric motorcycles, electric bikes, electric scooters, and related accessories under the Fly E-Bike brand. It offers 27 E-motorcycle products, 37 E-bike products and 38 E-scooter products.